Serum Selenium Levels in Ischaemic Heart Disease

Year 2007, Volume: 35 Issue: 2, 101 - 104, 01.04.2007

Afife İzbırak

Abstract

Selenium is an essential element and a cofactor required to maintain glutathione peroxidase activity. Its deficiency mayinduce modification in the cellular antioxdative status and the appearence of different diseases such as cardiovascular diseases and cancer. This study was conducted to determine whether an association exists between serum selenium levels and ischaemic heart disease. Serum selenium concentrations of the test and control groups weremeasured with hydride generation atomic absorbtion spectrometry. Statistical analysis indicated that there is a significant difference between the serum selenium levels of two groups

Keywords

Serum selenium, ischaemic heart disease, cellular antioxidants

References

• 1. Xia, J., Hill, K.E., and Burke, R.F., Biochemical studies of a selenium-deficient population in China: measurement of selenium, glutathione peroxidase and other oxidant defence indices in blood. J Nutr ,119, 1318-1326, 1989.
• 2. Magos, L., and Webb, M., The interaction of selenium with cadmium and mercury. CRC Crit Rev Toxicol ,8, 1-42, 1980.
• 3. Andersen, O., and Nielsen, J.B., Effects of simultaneous low-level dietary supplementation with inorganic and organic Se on blood and organ toxic levels of metals in mice. J Trace Elem Elect Health Dis, 7, 122, 1993.
• 4. Hui-Min, J., Guo'an, H., Xi, C., and Hongjun, Z., Effect of selenium on the change in cadmium-induced distribution of trace elements in pregnant rats. Trace Elem Elect, 14, 9-12, 1997.
• 5. Willett, W.C., Polk, B.F., Morris, J.S., Stanmpfer, M.J., Pressil, S., Rosner, B., Taylor, J.O., Schneider, K., and Hames, C.G., Prediagnostic serum selenium and risk of the cancer. Lancet, 2,130-134, 1983.
• 6. Helzlsouer, K.J., Comstock, G.W., and Morris, J.S., Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol and subsequent bladder cancer. Cancer Res, 49, 6144- 6148, 1989.
• 7. Overvad, K., Selenium and cancer in role of trace elements for health promotion and disease prevention, Sandstrom, B., and Walter , P. (eds) Kargel, Basel, 141-149, 1998.
• 8. Salonen, J.T., Salonen, R., Seppanen, K., Kantola, M., Paviainen, M., Alfthan, G., Maenpaa, P.H., Taskinen, E., and Rauramaa, R., Relationship of serum selenium and antioxidants to plasma lipoproteins, platelets aggregability and prevalent ischaemic heart disease in eastern Finnish men. Atherosclerosis, 70, 155-160, 1988.
• 9. Korpela, H., Kumpulainen, J., Jussila, E., Kemila, S., Kaariainen, M., Kaariainen, T., and Sotaniemi, E.A., Effect of selenium supplementation after acute myocardial infarction. Res Commun Chem Pathol Pharmacol, 65, 249-252, 1989.
• 10. Korpela, H., Selenium in cardiovascular diseases-an update. J Trace Elem Electrolytes Health Dis,7,115, 1993
• 11. Hattunen, J.K., Selenium and cardiovascular diseases- an update. Biomed and Environ Sci, 10, 220-226, 1997.
• 12. Johansson,E., Selenium and its protection against the effects of mercury and silver. J Trace Elem Electrolytes Health Dis, 54, 273- 274, 1991.
• 13. Arthur, J.R., and Beckett, G.J., Selenium deficiency and tyroid homone metabolism. In Selenium In Bioloy And Medicine, Wendel, A. (Ed.), Berlin, Springer, 1989.
• 14. Arthur, J.R., Nicol, F., and Beckett, G.J., Hepatic iodothyronine 5' deiodinase:The role of selenium. Biochem J, 227, 537-540, 1990.
• 15. Clark, L.C., The epidemiology of selenium and cancer. Fed Proc, 44, 2584-2589, 1985.
• 16. Clark, L.C., and Combs, J.F. Jr., Selenium compounds and the prevention of cancer: Research needs and public health imlications. J Nut, 116, 170-176, 1986.
• 17. Combs, J.F.Jr., and Mercurio, S.D., Selenium and oxidative injury. In Nutritional diseases: Research directions in comperative pathology. Scarpelli, D., and Magaki, G. (Eds. ) New York, Liss, 1986.
• 18. Levander, O.A., Clinical consequences of low selenium intake and its relationship to vitamin E. Ann NY Acad Sci, 393,70-72, 1982.
• 19. Normura, A., Heilburn, L.K., Morris, J.S., and Stemmermann, G.N., Serum selenium and the risk of cancer by specific sites: Case-control analysis of prospective data. J Natl Cancer Inst, 79, 103-108, 1987.
• 20. Salonen, J.T., Selenium in ischaemic heart disease. Int J Epidemiol, 16, 323-328,1987. 21. WHO World Health Organization. Selenium and selenium compounds. JARC Monographs 9, 245-260, 1975.
• 22. Lou, H., Wu, R., and Fu, Y., Relation between selenium and cancer of uterine cervix. Chinese J Oncol 17, 112-114, 1995.
• 23. Fleet, J.C., Dietary selenium repletion may reduce cancer incidence in people at high risk who live in areas with low soil selenium. Nutr Rev, 55,277-279, 1997.
• 24. Cowgill, U.M., The distribution of selenium and mortality owing to acquired immune deficiency syndrom in the continental United States. Biol Trace Elem Res, 56, 43-61, 1997.
• 25. Ward, K.P., Arthur, J.R., Russell, G., and Aggett, P.J., Blood selenium content and glutathione peroxidase activity in children with cystic fisrosis, coliac disease, asthma, and epilepsy. Eur J Pediatr, 142, 21-24, 1984.
• 26. Hinks, L.J., Inwards, K.D., Lloyd, B., and Clayton, B., Reduced concentrations of selenium in mild Crohn's disease. J Clin Pathol, 41, 198- 201, 1988.
• 27. Robberecht, H., Deelstra, H., and Van Grieken, R., Determination of selenium in blood components by X-ray emission spectrometry: Procedures, concentration levels and health implications. Biol Trace Elem Res, 25, 149-185, 1990.
• 28. Mtsuda, A., Kimura, M., and Itokawa, Y., Selenium level and glutathione peroxidase activity in plasma , eryhrocytes and platelets of healthy Japanese volunteers. J Nutr Sci Vitaminol, 43, 497-504, 1997.
• 29. Van Cauwenbergh, R., Robberdeccht, H., Deelstra, H., picramenos, D., and Kostakpoulos, A., Selenium concentrations in healthy Greek adults. J Trace Elem electrolytes Health Dis, 8, 99-109, 1994.
• 30. Scieszka, M., Danch, A., Machalski, M., and Drozda, M., Plasma selenium concentration in patients with stomach and colon cancer in the upper Silesia. Neoplasma, 44, 395-397, 1997.
• 31. Hughes, K., and Ong, C., Vitamins, selenium, iron, and coronary heart disease risk in Indians, Malays, and Chinese in Singhapore. J. Epidemiol and Community Health, 52, 181-185, 1998.
• 32. Makropoulos, W., Heintz, B., and Stefanidis, I., Selenium deficiency and thyroid function in acute renal failure. Renal Failure, 19, 129-136, 1997.
• 33. Chen, X.S., Yang, G.Q., Chen, X.C., Wen, Z.M., and Ge, K.Y., Studies on the relations of selenium and Keshan disease. Biol Trace Elem Res, 2, 97-107, 1980.
• 34. Keshan Disease Research Group Of The Chinese Academy Of Medical Sciences, Beijing, Epidemiological studies on the etiologic relationship of selenium and Keshan disease. Chin Med J, 92, 477-482, 1979.
• 35. Salonen, J.T., Alfthan, G., Huttunen, J.K., Pikkarainen, J., and Puska, P., Association between cardiovascular death and myocardial infarction and serum selenium in a matchedpair longitutional study. Lancet, 2, 175-191, 1982.
• 36. Salonen, J.T., Salonen, R., Pentilla, J., Jauhiainen, M., Kantola, M., Lappetelainen, R., Maenpaa, P.H., Alfthan, G., and Puska, P., Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol, 56, 226-231, 1985.
• 37. Miettinen, T.A., Alfthan, G., Huttunen, J.K., Pikkarainen, J., Naukkarinen, V., Mattila, S., and Kumlint, t., Serum selenium concentration related to myocardial infarction and fatty acid content of serum lipids. Br Med J, 287, 517- 519, 1983.
• 38. Virttamo, J., Valkeila, E., Alfthan, G., Punsar, S., Huttunen, J.K., and Karvonen, M., Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol 122, 276-282, 1985.
• 39. Kok, F.J., De Bruijn, A.M., Vermeeren, R., Hofman, A., vanlaar, A., De Bruin, M., Hermus, R.J., and Valkenburg, H.a., Serum selenium, vitamin antioxdants and the cardivascular mortality: A 9 year follow-up study in the Netherlands. Am J Clin Nutr, 45, 462-468, 1987.
• 40. Ringstad, J., And, D.S., Thelle, D.S., Risk of myocardial infarction in relation to serum concentrations of selenium. Acta Pharmacol Toxicol, 59, 336-339, 1986.
• 41. Weltz, B., Wolynetz, M., Verlinden, M., Interlaboratory trial on the determination of selenium in lyophilizied human serum, blood, and urine using hydride generation atomic absorbtion spectrometry. Pure and Applied Chem, 59(71), 927-936, 1987.
• 42. Arıcı, H., İstatistik, Meteksan Yayınları, s 230, 1991.
• 43. Oster, O., Prellwitz, W., Kaspen, W., Meinertz, T., Congestive cardiomyopathy and the selenium content of serum. Clin Chim Acta, 128, 125-132, 1983.
• 44. Al-Saleh, I., Selenium status in Saudi Arabia. J Trace Elem in Medicine and Biology, 14(3), 154-160,2000.
• 45. Al-Saleh, I., Billedo,G., El-Doush,I., El-Din Mohammed, G., and Yosef,G., Selenium and vitamins status in Saudi children. Clinica Chimica Acta, 368(1-2), 99-109, 2006.